News

BATESVILLE, Ind., March 31, 2025 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: HI) announced today that it has completed the previously announced sale of its majority interest in the Milacron injection ...
BATESVILLE, IN—Robert M. VanHimbergen, the Senior Vice President and Chief Financial Officer of Hillenbrand, Inc. (NYSE:HI), recently acquired a significant amount of the company's stock.